Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lova Sun

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
JAMA Oncology|May 28, 2021
Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?Lova Sun, Jeremy L Warner, Ravi B Parikh
Oral Oncology|August 19, 2024
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)Lova Sun, Roger B Cohen, A Dimitrios Colevas
Seminars in Radiation Oncology|February 21, 2021
Systemic Therapy for Mutation-Driven NSCLCLova Sun, Melina E Marmarelis, Corey J Langer
Clinical Lung Cancer|April 30, 2026
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?Matthew Lee, Shuai Wang, Lova Sun, et al.
Thrombosis and Haemostasis|January 15, 2016
Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysisLova Sun, Phyllis A Gimotty, Suvasini Lakshmanan, et al.
JACC. Cardiooncology|October 10, 2022
Considerations of Competing Risks Analysis in Cardio-Oncology Studies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewYimei Li, Lova Sun, Danielle S Burstein, et al.
American Journal of Epidemiology|March 2, 2013
The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational studyEili Y Klein, Lova Sun, David L Smith, et al.
Current Oncology Reports|February 22, 2023
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer TreatmentNikhil Yegya-Raman, Eva Berlin, Steven J Feigenberg, et al.
Frontiers in Oncology|March 27, 2026
Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survivalKewen Qu, Margaret Stalker, Wei-Ting Hwang, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
JAMA Oncology|May 28, 2021
Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?Lova Sun, Jeremy L Warner, Ravi B Parikh
Oral Oncology|August 19, 2024
Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)Lova Sun, Roger B Cohen, A Dimitrios Colevas
Seminars in Radiation Oncology|February 21, 2021
Systemic Therapy for Mutation-Driven NSCLCLova Sun, Melina E Marmarelis, Corey J Langer
Clinical Lung Cancer|April 30, 2026
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?Matthew Lee, Shuai Wang, Lova Sun, et al.
Thrombosis and Haemostasis|January 15, 2016
Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysisLova Sun, Phyllis A Gimotty, Suvasini Lakshmanan, et al.
JACC. Cardiooncology|October 10, 2022
Considerations of Competing Risks Analysis in Cardio-Oncology Studies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewYimei Li, Lova Sun, Danielle S Burstein, et al.
American Journal of Epidemiology|March 2, 2013
The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational studyEili Y Klein, Lova Sun, David L Smith, et al.
Current Oncology Reports|February 22, 2023
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer TreatmentNikhil Yegya-Raman, Eva Berlin, Steven J Feigenberg, et al.
Frontiers in Oncology|March 27, 2026
Recurrent/metastatic relapse after definitive treatment for HNSCC: timing, patterns, and survivalKewen Qu, Margaret Stalker, Wei-Ting Hwang, et al.
European Thyroid Journal|November 1, 2024
Real world outcomes of cabozantinib therapy in poorly differentiated thyroid carcinomaOmar Elghawy, Adam Barsouk, Jessica Xu, et al.
Pageof 9